AGYS
Agilysys, Inc.
AGYS's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over AGYS overall, supported by stronger modeled upside and stronger fundamentals.
AGYS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
AGYS's revenue, profitability, cash flow and balance sheet are all currently healthy.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
AGYS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 34x | $52.61 | -57% |
| Forward | 42x | $122 | — |
| Current | 77x | $122 | — |
| Fair | 133x | $209 | +72% |
| Expensive | 214x | $336 | +176% |
Historical ranges are pointers, not guarantees.
AGYS's PE is in its fair range at 77x. If earnings grow as analysts expect, today's price would be 42x next year's earnings, in its cheap range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over AGYS in the historical PE scenario, which offers more potential upside but is not a forecast.
AGYS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for AGYS, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
AGYS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.91 | +85% |
| Q3 2026 | $1.57 | +85% |
| Q2 2026 | $1.52 | +210% |
| Q1 2026 | $1.37 | +67% |
| Q4 2025 | $1.06 | +31% |
| Q3 2025 | $0.85 | -76% |
| Q2 2025 | $0.49 | -87% |
| Q1 2025 | $0.82 | -74% |
| Q4 2024 | $0.81 | -75% |
AGYS's earnings per share have fallen from their peak: $1.57 over the past year, against $3.63 in mid-2024.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over AGYS on earnings, with more consistent year-over-year improvement.
AGYS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $93.4M | +18% |
| Q2 2026 | $87.7M | +14% |
| Q1 2026 | $82.9M | +12% |
| Q4 2025 | $80.4M | +16% |
| Q3 2025 | $79.3M | +16% |
| Q2 2025 | $76.7M | +21% |
| Q1 2025 | $74.3M | +19% |
| Q4 2024 | $69.6M | +15% |
AGYS's revenue has grown year over year for 22 quarters in a row: $93M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -1.5 points |
| Q2 2026 | 11% | +5.2 points |
| Q1 2026 | 15% | +8.1 points |
| Q4 2025 | 15% | +3.9 points |
| Q3 2025 | 18% | +12 points |
| Q2 2025 | 5.9% | -3.2 points |
| Q1 2025 | 7.2% | +1.6 points |
| Q4 2024 | 11% | -2.2 points |
AGYS's operating margin was 16% last quarter, down 1.5 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over AGYS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over AGYS on profitability, with a higher operating margin.
AGYS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.8M | -1.2% |
| Q2 2026 | $7.3M | +$12.3M |
| Q1 2026 | $35.4M | +34% |
| Q4 2025 | $22.7M | +15% |
| Q3 2025 | $15M | +153% |
| Q2 2025 | -$5M | -2274% |
| Q1 2025 | $26.5M | -9.8% |
| Q4 2024 | $19.7M | +75% |
AGYS generated $80M in free cash flow over the past year, up 43% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over AGYS on cash flow, with more consistent year-over-year improvement.
AGYS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +157K shares |
| 1 year | +0.6% | +180K shares |
| 3 years | +9.4% | +2.5M shares |
| 5 years | +12% | +3.2M shares |
| Available history | +23% | +5.3M shares |
AGYS has the edge over MU on shareholder dilution, with a more favorable share count trend.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
AGYS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.4x | Net Cash |
| Q2 2026 | -2.2x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.8x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
AGYS has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
AGYS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.4 | Neutral |
| Stochastic | 79.9 | Neutral |
AGYS's weekly RSI is 63 (neutral) and its Stochastic is 80 (neutral).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
AGYS PE vs Technology Sector
| Metric | AGYS | Sector median | Relative |
|---|---|---|---|
| PE | 77x | 28x | 178% above |
| PE % | 37 | 35 | 2 pts above |
AGYS is trading at 77x earnings, a 178% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over AGYS on valuation relative to its sector.
AGYS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $111.6 | 8.9% above |
| 20 week MA | $109.7 | 11% above |
| 50 week MA | $96.9 | 25% above |
| 100 week MA | $99.9 | 22% above |
| 200 week MA | $93.9 | 29% above |
AGYS has the edge over MU on trend strength, trading above more of its moving averages.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
AGYS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.5 | $41.0 | +61% |
| 2021 | $41.0 | $44.4 | +8.3% |
| 2022 | $44.4 | $80.1 | +80% |
| 2023 | $80.1 | $84.8 | +5.9% |
| 2024 | $84.8 | $135.6 | +60% |
| 2025 | $135.6 | $121.5 | -10% |
| 2026 YTD | $121.5 | $121.6 | +0.1% |
AGYS has finished higher in five of the last six years, three of them by more than 50%. It's roughly flat so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over AGYS on returns for 2026, with the stronger performance.